The legacy success of Viagra has established a peculiar shadow over the wider pharmaceutical landscape. While copyright initially enjoyed substantial profits , generic versions now chip away at its market share , presenting challenges for stakeholders considering positions in affected companies.

The emergence of so-called "High Gambler's Viagra" – often referring to exceptionally high doses administered by rogue physicians – represents a particularly alarming trend. While typical dosages of Viagra are intended for treating erectile dysfunction safely in most men, these significantly elev